相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。BACE1 inhibition more effectively suppresses initiation than progression of beta-amyloid pathology
Finn Peters et al.
ACTA NEUROPATHOLOGICA (2018)
Modulation of gamma- and beta-Secretases as Early Prevention Against Alzheimer's Disease
Iryna Voytyuk et al.
BIOLOGICAL PSYCHIATRY (2018)
Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibition Impairs Synaptic Plasticity via Seizure Protein 6
Kaichuan Zhu et al.
BIOLOGICAL PSYCHIATRY (2018)
Combination anti-Aβ treatment maximizes cognitive recovery and rebalances mTOR signaling in APP mice
Angie C. A. Chiang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
BACE1 deletion in the adult mouse reverses preformed amyloid deposition and improves cognitive functions
Xiangyou Hu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study
Brian A. Gordon et al.
LANCET NEUROLOGY (2018)
Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer's Disease
Michael F. Egan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Highlights in BACE1 Inhibitors for Alzheimer's Disease Treatment
Judite R. M. Coimbra et al.
FRONTIERS IN CHEMISTRY (2018)
The BACE-1 inhibitor CNP520 for prevention trials in Alzheimer's disease
Ulf Neumann et al.
EMBO MOLECULAR MEDICINE (2018)
Axonal organization defects in the hippocampus of adult conditional BACE1 knockout mice
Ming-Hsuan Ou-Yang et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Beta-secretase inhibitors in phase I and phase II clinical trials for Alzheimer's disease
Charbel E-H. Moussa
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2017)
BACE inhibition-dependent repair of Alzheimer's pathophysiology
Aylin D. Keskin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Cell-Penetrating Peptides: From Basic Research to Clinics
Giulia Guidotti et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
Role of BACE1 in Alzheimer's synaptic function
Brati Das et al.
TRANSLATIONAL NEURODEGENERATION (2017)
Decreased Plasma β-Amyloid in the Alzheimer's Disease APP A673T Variant Carriers
Henna Martiskainen et al.
ANNALS OF NEUROLOGY (2017)
Visualizing APP and BACE-1 approximation in neurons yields insight into the amyloidogenic pathway
Utpal Das et al.
NATURE NEUROSCIENCE (2016)
The amyloid hypothesis of Alzheimer's disease at 25years
Dennis J. Selkoe et al.
EMBO MOLECULAR MEDICINE (2016)
Functions of the Alzheimer's Disease Protease BACE1 at the Synapse in the Central Nervous System
Kathryn M. Munro et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2016)
Euthanasia using gaseous agents in laboratory rodents
A. M. Valentim et al.
LABORATORY ANIMALS (2016)
PEP-FOLD3: faster denovo structure prediction for linear peptides in solution and in complex
Alexis Lamiable et al.
NUCLEIC ACIDS RESEARCH (2016)
The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer's disease patients
Matthew E. Kennedy et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
BACE1 Physiolocical Functions May Limit Its Use as Therapeutic Tarcet for Alzneimer's Disease
Soraia Barao et al.
TRENDS IN NEUROSCIENCES (2016)
Specific Inhibition of β-Secretase Processing of the Alzheimer Disease Amyloid Precursor Protein
Saoussen Ben Halima et al.
CELL REPORTS (2016)
BACE1 inhibition as a therapeutic strategy for Alzheimer's disease
Robert Vassar
Journal of Sport and Health Science (2016)
Stepping closer to treating Alzheimer's disease patients with BACE1 inhibitor drugs
Riqiang Yan
TRANSLATIONAL NEURODEGENERATION (2016)
Beneficial Effects of the β-Secretase Inhibitor GRL-8234 in 5XFAD Alzheimer's Transgenic Mice Lessen During Disease Progression
Latha Devi et al.
CURRENT ALZHEIMER RESEARCH (2015)
Centrally Delivered BACE1 Inhibitor Activates Microglia, and Reverses Amyloid Pathology and Cognitive Deficit in Aged Tg2576 Mice
Deepak R. Thakker et al.
JOURNAL OF NEUROSCIENCE (2015)
The Potent BACE1 Inhibitor LY2886721 Elicits Robust Central Aβ Pharmacodynamic Responses in Mice, Dogs, and Humans
Patrick C. May et al.
JOURNAL OF NEUROSCIENCE (2015)
Alzheimer's disease
Colin L. Masters et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Cell-Penetrating Peptides Selectively Cross the Blood-Brain Barrier In Vivo
Sofie Stalmans et al.
PLOS ONE (2015)
BACE1 (beta-secretase) inhibitors for the treatment of Alzheimer's disease
Arun K. Ghosh et al.
CHEMICAL SOCIETY REVIEWS (2014)
Molecular Mechanisms of Alzheimer Disease Protection by the A673T Allele of Amyloid Precursor Protein
Janice A. Maloney et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Targeting the β secretase BACE1 for Alzheimer's disease therapy
Riqiang Yan et al.
LANCET NEUROLOGY (2014)
BACE1 inhibitor drugs in clinical trials for Alzheimer's disease
Robert Vassar
ALZHEIMERS RESEARCH & THERAPY (2014)
Dopamine induces apoptosis in APPswe-expressing Neuro2A cells following Pepstatin-sensitive proteolysis of APP in acid compartments
Monica Cagnin et al.
BRAIN RESEARCH (2012)
A mutation in APP protects against Alzheimer's disease and age-related cognitive decline
Thorlakur Jonsson et al.
NATURE (2012)
Cell-Penetrating Peptides, PepFects, Show No Evidence of Toxicity and Immunogenicity In Vitro and In Vivo
Julia Suhorutsenko et al.
BIOCONJUGATE CHEMISTRY (2011)
β-Secretase inhibitor GRL-8234 rescues age-related cognitive decline in APP transgenic mice
Wan-Pin Chang et al.
FASEB JOURNAL (2011)
DAPK1 Interaction with NMDA Receptor NR2B Subunits Mediates Brain Damage in Stroke
Weihong Tu et al.
CELL (2010)
A Noncompetitive BACE1 Inhibitor TAK-070 Ameliorates Aβ Pathology and Behavioral Deficits in a Mouse Model of Alzheimer's Disease
Hiroaki Fukumoto et al.
JOURNAL OF NEUROSCIENCE (2010)
The Use of Inhibitors to Study Endocytic Pathways of Gene Carriers: Optimization and Pitfalls
Dries Vercauteren et al.
MOLECULAR THERAPY (2010)
Excitotoxicity through Ca2+-permeable AMPA receptors requires Ca2+-dependent JNK activation
M. Vieira et al.
NEUROBIOLOGY OF DISEASE (2010)
In vivo biodistribution and efficacy of peptide mediated delivery
Peter Jarver et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2010)
Effect of RasGAP N2 Fragment-Derived Peptide on Tumor Growth in Mice
David Michod et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Picomolar Amyloid-β Positively Modulates Synaptic Plasticity and Memory in Hippocampus
Daniela Puzzo et al.
JOURNAL OF NEUROSCIENCE (2008)
Partial reduction of BACE1 has dramatic effects on Alzheimer plaque and synaptic pathology in APP transgenic mice
Lisa McConlogue et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
A comprehensive model for the cellular uptake of cationic cell-penetrating peptides
Falk Duchardt et al.
TRAFFIC (2007)
Intraneuronal Aβ causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice
LM Billings et al.
NEURON (2005)
Treatment of terminal peritoneal carcinomatosis by a transducible p53-activating peptide
EL Snyder et al.
PLOS BIOLOGY (2004)
BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease
M Ohno et al.
NEURON (2004)
A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia
T Borsello et al.
NATURE MEDICINE (2003)
Triple-transgenic model of Alzheimer's disease with plaques and tangles:: Intracellular Aβ and synaptic dysfunction
S Oddo et al.
NEURON (2003)
HADDOCK: A protein-protein docking approach based on biochemical or biophysical information
C Dominguez et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2003)
Treatment of ischemic brain damage by perturbing NMDA receptor-PSD-95 protein interactions
M Aarts et al.
SCIENCE (2002)
Endocytic pathway abnormalities precede amyloid β deposition in sporadic Alzheimer's disease and Down syndrome -: Differential effects of APOE genotype and presenilin mutations
AM Cataldo et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
分享论文
